CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of Washington
Study ID
NCT05127837
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • CBTpro — BEHAVIORAL
    CBTpro is a novel spoken language technology tool to support high-quality skills training in CBT for psychosis.

Study Details

The primary objective of this grant is to develop and evaluate an Artificial Intelligence-based clinical training tool--CBTpro--to support high-quality skills training in CBT for psychosis (CBTp). CBTpro will provide a rapid means of scaling and sustaining high-quality CBTp in routine care settings across the US.

Key Dates

Start date
Jun 28, 2022
Status verified
Feb 2026
Primary completion
Dec 9, 2024
Completion
Dec 9, 2024

Study Design

Enrollment
601 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • No Intervention: Treatment as Usual (TAU)
    CBT for psychosis distance learning course.
  • Experimental: CBTpro
    In addition to TAU, clinicians and clients receive the CBTpro training.

Primary Outcome Measure

Revised Green Paranoid Thoughts Scale (R-GPTS) Mean Score [ Time Frame: 0,3,6 months ]

Locations (13)

FacilityCityStateZIPSite coordinators
South Central Health and Rehabilitation ProgramsLos AngelesCalifornia90003-
PsynergyMorgan HillCalifornia93927-
TelecareSan JoseCalifornia95116-
Integrated Services of KalamazooKalamazooMichigan49007-
Community Mental Health Authority of Clinton, Eaton, and Ingham Counties (CEICMH)LansingMichigan48823-
Coleman Health ServicesAkronOhio44223-
PeaceHealthEugeneOregon97401-
CascadiaPortlandOregon97207-
Lifeworks NWPortlandOregon97221-
Harborview Medical CenterSeattleWashington98104-
Sound HealthSeattleWashington98122-
Frontier Behavioral HealthSpokaneWashington99208-
Comprehensive HealthcareYakimaWashington98902-

Find similar trials in Los Angeles, CA

Related Studies